Lars Henrik Jensen

36PUBLICATIONS
110CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursVideo processingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 15, 2026
Targeting Reactive Species Stress and Nutrient Sensing to Enhance NK-Cell Function: Mechanistic Strategies for Overcoming Pancreatic Cancer Progression and Resistance Through Supplement Therapy.

|May 05, 2026
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

|Apr 29, 2026
HPV-Related Cancers in Solid Organ Transplant Recipients: A Nationwide Danish Cohort Study.

|Dec 31, 2025
Impact of Cross-Sectoral Video Consultation on Perceived Care Coordination and Information Satisfaction in Cancer Care: Randomized Controlled Trial.

Fereshteh Baygi, Theis Bitz Trabjerg, Lars Henrik Jensen

|Sep 19, 2025
The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST.

Mette M Steiniche, Sidsel C Lindgaard, Inna M Chen

|Aug 04, 2025
MRI T1 relaxation time for evaluating early complete response to neoadjuvant treatment in rectal cancer: measurement at six weeks - a protocol article.

Mathias Rosenfeldt Byriel, Torben Frøstrup Hansen, Hans Bjarke Rahr

Pageof 6

Frequent Collaborators

16 joint publications

Torben Frøstrup Hansen

4 joint publications

Caroline Emilie B Thomsen

4 joint publications

Jens Søndergaard

4 joint publications

Rikke Fredslund Andersen